Private Equity 3 Days

Last updated: June 4, 2026, 8:31 AM ET

AI Investments & Strategic Moves

Private equity firms are intensifying their focus on artificial intelligence, with deals and partnerships reflecting a competitive rush to capitalize on the technology. Scotch, an AI-native software platform for liquor retailers, raised $20M in Series A funding to disrupt legacy retail tech, leveraging machine learning to optimize inventory and customer engagement. Meanwhile, Kirkland & Ellis has partnered with Palantir to develop AI tools tailored for private equity fundraising, aiming to streamline due diligence and enhance deal sourcing. At the PEI Group’s Women in Private Markets Summit, leaders like Raytheon’s Sunaina Sinha Haldea emphasized AI’s role in value creation, noting its growing influence on deal execution and exit strategies. KPMG’s Tilman Ost further highlighted the nuanced demand for AI, stating that while software remains attractive, it must be “niche, mission-critical” to justify investment. These moves underscore a broader trend: AI is no longer a peripheral consideration but a central driver of private equity strategy.

Notable PE Deals & Acquisitions

Private equity activity remains robust, with firms pursuing strategic acquisitions across diverse sectors. Brand Velocity Group’s acquisition of RCX Sports, backed by Hamilton Lane and St. Cloud Capital, signals a focus on sports and wellness assets, though details on valuation remain sparse. In healthcare, Main Capital-backed Sensire acquired a majority stake in Dyzle, an environmental monitoring provider, to expand its footprint in regulated industries. Similarly, PSG Equity invested in CHR Group, a digital food safety software firm, to strengthen its presence in compliance tech. Defense tech also attracted attention, as Sixth Street Partners neared a $1B+ investment in Kpler, a commodities data platform, while APG explored earlier-stage tech bets, including AI-driven defense solutions. These deals highlight private equity’s appetite for high-growth, specialized markets.

Fundraising Activity & Capital Raises

Fundraising momentum continues, with firms securing significant capital to fuel growth. Benchmark broke tradition by launching its first $2B growth fund, signaling a shift toward larger-scale investments. Crescent Capital Group closed Crescent Direct Lending Fund IV at $10.8B, its largest fund to date, reflecting strong demand for direct lending in the U.S. . In Europe, Eurazeo raised €3.9B for its direct lending fund, exceeding targets and boosting its program to €5.5B. Meanwhile, Vinted Ventures led a $26M round for Revolut, backing the fintech’s expansion into credit products. These raises underscore investor confidence in private equity’s adaptability, particularly in tech and financial services.

Sector-Specific Trends: Defense, Life Sciences, and Fintech

Defense and life sciences remain key areas of interest. Anduril, a defense tech firm, saw valuations surge as U.S. government spending proposals increased, with Ross Fubini’s early investment now part of a broader trend in military tech. In life sciences, Walder Capital invested in Evovest, an AI-driven asset manager, while 3i backed Nutergia, a natural supplements brand distributing through pharmacies. Fintech also saw activity, with Gradient Labs doubling its Series A to $26M for AI-powered finance tools, and Dwelly leveraging AI to optimize its real estate rollup strategy. However, scrutiny is mounting: KPMG warned that tech-adjacent deals in Europe face heightened regulatory risks unless they solve specific problems.

Market Dynamics & Outlook

Private equity faces evolving challenges, from talent shortages to shifting investor expectations. The secondaries market, highlighted by JMAN Group’s emphasis on data quality for exits, is grappling with a talent crunch as firms compete for experienced professionals. Meanwhile, Blackstone’s $13.1B Asia fund closed at a hard cap, reflecting strong regional demand. AI’s role will likely deepen, but as Celonis’ CEO noted, adoption lags behind expectations, requiring tailored solutions rather than generic implementations. With sectors like defense and life sciences offering high-growth potential, private equity’s focus on niche, impactful